Aegerion Pharmaceuticals
Latest round
- Series B
Last raised
- Nov 2007
Total raised
- $40M
Investors
- 4
About Aegerion Pharmaceuticals
Aegerion Pharmaceuticals, Inc.Aegerion Pharmaceuticals, Inc. specializes in creating treatments for rare diseases, established in 2005 in Cambridge, US.50 each.The company provides innovative therapies aimed at treating rare diseases. Its product portfolio includes specialized medications that address significant health challenges for patients suffering from specific conditions.In 2015, Aegerion Pharmaceuticals, Inc.Following its IPO in October 2010, Aegerion Pharmaceuticals, Inc.34 mn to further develop its product offerings and explore additional rare disease therapies. The company aims to expand its market presence beyond North America into Europe and Asia by 2025, focusing on enhancing its portfolio with new therapeutic options designed to meet the needs of patients in these regions.
Who invested in Aegerion Pharmaceuticals
4 investors across 2 rounds
See all investors in Aegerion Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aegerion Pharmaceuticals
Who invested in Aegerion Pharmaceuticals?
Aegerion Pharmaceuticals has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aegerion Pharmaceuticals raised?
Aegerion Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Aegerion Pharmaceuticals last raise money?
Aegerion Pharmaceuticals's most recent round on record is a Series B, in Nov 2007.
What does Aegerion Pharmaceuticals do?
Aegerion Pharmaceuticals is a pharmaceuticals company.
Where is Aegerion Pharmaceuticals headquartered?
Aegerion Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Aegerion Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Aegerion Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Aegerion Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.